Evidence map›Paper›PMID 34965008›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2022

Nanosized calcium deficient hydroxyapatites for tooth enamel protection.

Vita Zalite, Janis Lungevics, Jana Vecstaudza, Liga Stipniece, Janis Locs

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Nanosized calcium deficient hydroxyapatites for tooth enamel protection.Journal of biomedical materials research. Part B, Applied biomaterials · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vita ZaliteRudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.ORCID 0000-0002-4319-9334
Janis LungevicsDepartment of Mechanical Engineering and Mechatronics, Faculty of Mechanical Engineering, Transport and Aeronautics, Riga Technical University, Riga, Latvia.
Jana VecstaudzaRudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.
Liga StipnieceRudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.
Janis LocsRudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.

Funding

European Regional Development Fund 1.1.1.2/VIAA/3/19/459European Union's Horizon 2020 857287
6 · The paper itself

Abstract

Calcium phosphates (CaP) are extensively studied as additives to dental care products for tooth enamel protection against caries. However, it is not clear yet whether substituted CaP could provide better enamel protection. In this study we produced, characterized and tested in vitro substituted and co-substituted calcium deficient hydroxyapatite (CDHAp) with Sr

Indexed as

DurapatiteTooth RemineralizationAnimalsCalciumCalcium PhosphatesCattleDental EnamelFluoridesHydrogen-Ion ConcentrationSuspensionsCalciumCalcium PhosphatesDurapatiteFluoridesSuspensionscalcium phosphateenamel protectionnanoparticlestooth enamel

Identifiers

PMID34965008
PMCPMC9306847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.